Activation of human blood lymphocytes and monocytes by the streptococcal preparation OK432: Enhanced generation of soluble cytotoxic factors

This publication has 16 references indexed in Scilit:

• Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes
  Cancer Immunology, Immunotherapy, 1984
• Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients
  Cancer Immunology, Immunotherapy, 1984
• Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432
  International Journal of Cancer, 1984
• Natural cytotoxicity of human blood monocytes: Production of monocyte cytotoxic factors (MCF) during interaction with tumor cells
  Immunology Letters, 1984
• Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
  The Journal of Immunology, 1983
• Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
  The Journal of Immunology, 1983
• Intrapleural administration of OK432 in cancer patients: Activation of nk cells and reduction of suppressor cells
  International Journal of Cancer, 1983
• Tumor cell killing by freshly isolated peripheral blood monocytes
  Cellular Immunology, 1981
• In vitro augmentation of natural killing activity by OK-432
  International Journal of Immunopharmacology, 1981
• Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy
  International Journal of Cancer, 1980